DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Taiwan
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
6814 logo

Lukas Biomedical Inc. Stock Price

TPEX:6814 Community·NT$795.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

6814 Share Price Performance

NT$19.00
-7.10 (-27.20%)
​
NT$19.00
-7.10 (-27.20%)
​
Price NT$19.00
Sun, 20 Sep 26
Share Pricen/a

6814 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and overvalued.

3 Risks
0 Rewards
View Full Analysis

Lukas Biomedical Inc. Key Details

NT$170.0m

Revenue

NT$68.2m

Cost of Revenue

NT$101.8m

Gross Profit

NT$193.9m

Other Expenses

-NT$92.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-2.20
59.88%
-54.14%
87.6%
View Full Analysis

About 6814

Founded
2002
Employees
87
CEO
Chaoan Liu
WebsiteView website
www.lukas-biomedical.com

Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.

Recent 6814 News & Updates

Recent updates

No updates

Lukas Biomedical Inc. Competitors

6949 logo

Pell Bio-Med Technology

Symbol: TWSE:6949
Market cap: NT$71.4b
6472 logo

Bora Pharmaceuticals

Symbol: TWSE:6472
Market cap: NT$56.6b
1795 logo

Lotus Pharmaceutical

Symbol: TWSE:1795
Market cap: NT$48.5b
7924 logo

TLC BioSciences

Symbol: TPEX:7924
Market cap: NT$45.3b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide